RT Journal Article
SR Electronic
T1 Estimating the end of the first wave of epidemic for COVID-19 outbreak in mainland China
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.14.20064824
DO 10.1101/2020.04.14.20064824
A1 Griette, Quentin
A1 Liu, Zhihua
A1 Magal, Pierre
YR 2020
UL http://medrxiv.org/content/early/2020/07/06/2020.04.14.20064824.abstract
AB Our main aim is to estimate the end of the first wave epidemic of COVID-19 outbreak in mainland China. We developed mathematical models to predict reasonable bounds on the date of end of the COVID-19 epidemics in mainland China with strong quarantine and testing measures for a sufficiently long time. We used reported data in China from January 20, 2020 to April 9, 2020. We firstly used a deterministic approach to obtain a formula to compute the probability distribution of the extinction date by combining the models and continuous-time Markov processes. Then we present the individual based model (IMB) simulations to compare the result by deterministic approach and show the absolute difference between the estimated cumulative probability distribution computed by simulations and formula. We provide the predictions of the end of the first wave epidemic for different fractions f of asymptomatic infectious that become reported symptomatic infectious.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by the National Natural Science Foundation of China (grant number: 11871007 (ZL)), NSFC and CNRS (Grant number: 11811530272 (ZL, PM)) and the Fundamental Research Funds for the Central Universities (ZL).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe use the data from WHO